MICHELLE MOURRE: Open Payments
NPI 1295331858 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 22 payments from 10 companies in 2025. Trend: 2023 $1,220 · 2024 $373 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Lilly USA, LLC | 3 | $78 |
| Novo Nordisk Inc | 3 | $64 |
| Eisai Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
| Insulet Corporation | 1 | $21 |
| Amgen Inc. | 1 | $18 |
Products named: FARXIGA, The Cologuard Plus Collection Kit, Wegovy, MOUNJARO, Leqembi, REXULTI, INGREZZA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
